We hypothesize that in addition to the lack of Type I IFN induction, the presence of a potent B6 Apobec3 gene could explain the weak antiviral effect of B6 Tetherin observed in acute Moloney MLV and LP-BM5 infections [13]. The gene discussed is BST2; the disease is infection.